E75.11 ICD-10-CM Code: Mucolipidosis IV
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Metabolic disorders (E70-E88)
E75.11
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMucolipidosis IV
A rare inherited metabolic disorder where fatty substances accumulate in cells throughout the body, particularly affecting the nervous system and causing progressive neurological symptoms.

Buddy Insight
Mucolipidosis IV is a rare autosomal recessive lysosomal storage disorder caused by MCOLN1 gene mutations affecting the TRPML1 ion channel.
CMS-HCC V28
00
RAF 0
CMS-HCC V24
00
RAF 0
ACA/HHS
00
RAF 0
ESRD/PACE
00
RAF 0
RXHCC
MappedHCC 41
RAF 0.0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for E75.11 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for E75.11 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for E75.11 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for E75.11 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for E75.11 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for E75.11 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for E75.11 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is E75.11 an HCC code?
No. E75.11 is a billable ICD-10-CM code but does not map to any HCC category in V28, V24, ESRD, or RxHCC.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work E75.11 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for E75.11
For E75.11to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed E75.11 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E75.11 is the ICD-10-CM diagnosis code for mucolipidosis iv. A rare inherited metabolic disorder where fatty substances accumulate in cells throughout the body, particularly affecting the nervous system and causing progressive neurological symptoms. E75.11 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering metabolic disorders (e70-e88).
E75.11 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.
Does not map to any HCC in V24, V28, or ESRD models. Maps only to RxHCC 41 (Rheumatoid Arthritis and Specified Autoimmune Disorders). This code carries no primary RAF weight in Medicare Advantage risk adjustment. Coders reviewing E75.11 should check whether additional documentation would support a more specific child code in the same hierarchy that does map to a payment HCC, capturing the correct specificity is the highest-impact RAF improvement available within accurate coding.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for E75.11 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This is a specific diagnosis requiring genetic confirmation; verify molecular testing results are documented
- •Ensure the diagnosis distinguishes mucolipidosis IV from other gangliosidoses in the medical record
Clinical Significance
Mucolipidosis IV is a rare autosomal recessive lysosomal storage disorder caused by MCOLN1 gene mutations affecting the TRPML1 ion channel. It presents with corneal clouding, progressive psychomotor retardation, and achlorhydria (absent stomach acid). Unlike many lysosomal disorders, it does not cause skeletal abnormalities or organomegaly. Accurate diagnosis is important as the clinical course and management differ from other gangliosidoses.
Documentation Requirements
- ✓Confirmed diagnosis of mucolipidosis IV
- ✓Genetic testing showing MCOLN1 gene mutations
- ✓Ophthalmologic findings including corneal clouding
- ✓Neurological assessment documenting developmental status
- ✓Gastric acid production assessment or documentation of achlorhydria
- ✓Documentation distinguishing from other mucolipidosis types (I, II, III)
Commonly Confused Codes
- •E75.10: Unspecified gangliosidosis: less specific; use E75.11 when ML IV is confirmed
- •E75.19: Other gangliosidosis: for gangliosidoses not classified as GM2 or mucolipidosis IV
- •E77.0: Defects in post-translational modification of lysosomal enzymes: mucolipidosis II and III are coded here
- •E77.1: Defects in glycoprotein degradation: another lysosomal disorder category
- •E75.00-E75.09: GM2 gangliosidosis codes: different lysosomal storage disease